Canada: Pharma In Brief - New Decisions Relating To Pharmaceutical Pricing Information Under Access To Information Law Are Released


Continuing a line of cases dealing with access to information surrounding dealings between government and pharmaceutical manufacturers, in two decisions released on November 6, 2013, the Ontario Information and Privacy Commissioner upheld certain governmental exemptions but released other information relating to contracts and other information held by the Ontario Ministry of Health and Long-Term Care.

Decision PO-3275

This case involved information contained in a number of records relating to volume discount payments received by the ministry from a number of drug manufacturers. The ministry had withheld portions of the information on the basis of third party information (section 17) and the government's own exemption as to economic interests (section 18). The records uncovered included a chart of estimated savings as a result of Listing/Pricing Agreements, information indicating the aggregate amount of savings to the government over 2007/2008, information as to the overall weighted average percentage of savings per drug product, and finally, two separate agreements between manufacturers and the ministry. The government and third parties claimed various exemptions and the requester and certain manufacturers appealed to the Commissioner.

In considering the government's claimed exemptions, the Commissioner upheld certain of them but denied others. In particular, in respect of information in the agreements that would disclose the actual amount of guaranteed savings/payments to the ministry and the process of how the figure is calculated, the Commissioner found that disclosure of the information could reasonably be expected to both prejudice the ministry's economic interests and be injurious to the Ontario government's financial interests.

However, in respect of the aggregate or summary information representing the ministry's savings overall for a particular period, the Commissioner found that the ministry had not provided sufficiently detailed and convincing evidence that disclosure of the information could reasonably be expected to result in the harms set out in section 18. The information related to a number of third parties. The Commissioner held there is no way to extrapolate the individual portion paid by a particular affected party. The Commissioner also found that the overall aggregate information does not qualify as third party information under section 17 of the Act. Notably, however, the Commissioner did find that the overall weighted average volume discount was subject to the government's claimed exemption, and could result in harm as it could affect the ministry's ability to negotiate favorable volume discount percentages in current and future negotiations. In the result, the Commissioner found the information to be exempt from release.

In respect of the two contracts between pharmaceutical companies and the government, the Commissioner found the pricing information to be exempt from release. However, in respect of the remaining portions of the two contracts at issue, the Commissioner found that the third party exemptions claimed under section 17(1) had no application. The three part test must be satisfied. While the information at issue (other than the pricing terms) was commercial or financial information, it was not "supplied" but rather was negotiated as between the parties. The remaining information in the agreements (other than the pricing/savings terms) was therefore ordered disclosed.

Decision PO-3276

This case involved an appeal of the government's decision to release certain information contained in a 4-page Letter of Intent from the Ministry of Health and Long-Term Care to the appellant pharmaceutical manufacturer, and a 2-page letter from the appellant to the ministry.

The ministry did not claim any exemptions in respect of the two records at issue, despite the fact that they did contain pricing information. While the adjudicator notes that, "The contents of a contract involving an institution and a third party will not normally qualify as having been "supplied" for the purpose of section 17(1). The provisions of a contract, in general, have been treated as mutually generated, rather than "supplied" by the third party, even where the contract is preceded by little or no negotiation or where the final agreement reflects information that originated from a single party." Nonetheless, the adjudicator held, "Based on my review of the records, I find that some sections of the letter of intent includes pricing information which, if disclosed, could permit the requester to accurately infer the appellant's baseline pricing. On this basis, I find that the portion of the letter of intent dealing with the pricing and payment information was supplied to the ministry for the purposes of section 17(1). I further find that this information would have been supplied with a reasonable expectation of confidentiality as section 11 of the record explicitly sets out the confidential terms of the agreement." The remainder of the contents of the Letter of Intent however were not found to have been supplied.

In respect of the two-page letter, the adjudicator found that it contained information that was "supplied" by the appellant to the ministry; it refers to a discussion between the appellant and the ministry and a possible agreement arising from that discussion. It was also found to contain commercial information supplied by the appellant, and with an implicit expectation of confidentiality.

Interestingly, while release of the pricing information was found to be likely to cause harm, the appellant did not provide "detailed and convincing evidence" of harm in respect of any information, according to the adjudicator. The adjudicator found that, "The failure of a party resisting disclosure to provide detailed and convincing evidence will not necessarily defeat the claim for exemption where harm can be inferred from other circumstances. However, only in exceptional circumstances would such a determination be made on the basis of anything other than the records at issue and the evidence provided by a party in discharging its onus."

In the result, the pricing information contained in the Letter of Intent was exempt from release, but all other portions of the Letter of Intent, and the entirety of the two-page letter, were ordered disclosed.


The two recent cases follow the earlier line of Ontario cases (see our Pharma in Brief report dated October 2, 2013 under which requesters have been denied access to pricing and financial information that is identifiable to specific manufacturers, but access has been granted to certain other types of information. These cases relate only to Ontario. To the extent that other provinces may have agreements with pharmaceutical manufacturers, the confidentiality of information will be determined under each province's legislation.

Link to decisions:



Norton Rose Fulbright Canada LLP

Norton Rose Fulbright is a global legal practice. We provide the world's pre-eminent corporations and financial institutions with a full business law service. We have more than 3800 lawyers based in over 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.

Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.

Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.

Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP, Norton Rose Fulbright South Africa (incorporated as Deneys Reitz Inc) and Fulbright & Jaworski LLP, each of which is a separate legal entity, are members ('the Norton Rose Fulbright members') of Norton Rose Fulbright Verein, a Swiss Verein. Norton Rose Fulbright Verein helps coordinate the activities of the Norton Rose Fulbright members but does not itself provide legal services to clients.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.